Learn More
Medchemexpress LLC Evixapodlin | 2374856-75-2 | 98.1% | 691.61 | 50 MG

Supplier: Medchemexpress LLC HY13840750MG
Evixapodlin (GS-4224) is a human PD-1/PD-L1 protein/protein interaction inhibitor with an IC50 of 0.213 nM. It exhibits anticancer and antiviral functions.
- Enhances IFN-γ and Granzyme B production in chronic hepatitis B (CHB) CD8+ T cells and CD4+ T cells.
- Increases the frequency of GrB+ cells among HBV-specific CD8+ and CD4+ T cells.
- In vivo treatment shows >90% PD-L1 target occupancy on tumor cells.
- Significantly inhibits tumor growth in a human PD-L1 expressing MC38 mouse colorectal tumor model.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.